当前位置: X-MOL 学术Annu. Rev. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Low-FODMAP Diet for Irritable Bowel Syndrome: What We Know and What We Have Yet to Learn.
Annual Review of Medicine ( IF 10.5 ) Pub Date : 2020-01-27 , DOI: 10.1146/annurev-med-050218-013625
Jerry Liu 1 , William D Chey 2 , Emily Haller 2 , Shanti Eswaran 2
Affiliation  

Irritable bowel syndrome (IBS) is the most prevalent of gastrointestinal (GI) conditions, affecting millions of people worldwide. Given that most IBS patients associate their GI symptoms with eating food, specific dietary manipulation has become an attractive treatment strategy. A diet low in FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) has generated the greatest level of scientific and clinical interest. Overall, 52-86% of patients report significant improvement of their IBS symptoms with elimination of dietary FODMAPs. Patients who experience symptom improvement with FODMAP elimination should undergo a structured reintroduction of foods containing individual FODMAPs to determine sensitivities and allow for personalization of the diet plan. This review discusses the literature surrounding the administration of the low-FODMAP diet and its efficacy in the treatment of IBS.

中文翻译:

肠易激综合征的低FODMAP饮食:我们所知道的以及我们尚需学习的知识。

肠易激综合症(IBS)是最普遍的胃肠道(GI)病状,影响着全球数百万人。鉴于大多数IBS患者将其胃肠道症状与饮食相联系,因此特定的饮食操作已成为一种有吸引力的治疗策略。FODMAP(可发酵的寡糖,二糖,单糖和多元醇)含量低的饮食引起了最高水平的科学和临床兴趣。总体而言,有52-86%的患者报告其IBS症状得到了明显改善,其中消除了饮食中的FODMAP。消除FODMAP会改善症状的患者应接受结构性重新引入含有个别FODMAPs的食物的测定,以确定敏感性并考虑饮食计划的个性化。
更新日期:2020-04-21
down
wechat
bug